WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
CORT
CORCEPT THERAPEUTICS INC
$2.55B24.20%19.60%21.67%34.30%0.205.1898.50%22.40%23.13%
INCY
INCYTE CORP
$12.07B14.70%11.20%17.79%53.00%0.323.4793.10%19.80%27.10%
AMLX
AMYLYX PHARMACEUTICALS INC
$137.60M12.40%10.70%12.47%22.80%0.195.6693.30%12.90%14.26%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$1.79B28.30%17.20%30.75%53.30%0.643.1179.30%22.30%34.50%
PBYI
PUMA BIOTECHNOLOGY INC
$234.44M35.40%7.20%25.79%28.50%3.201.4673.40%6.80%13.20%
BMRN
BIOMARIN PHARMACEUTICAL INC
$15.65B4.20%3.00%4.40%4.50%0.362.7479.20%8.30%10.30%
EXEL
EXELIXIS INC
$6.38B8.90%6.90%10.64%10.90%0.323.4795.70%11.10%14.00%
VYGR
VOYAGER THERAPEUTICS INC
$478.39M63.90%40.80%42.55%106.20%0.494.96100.00%52.90%48.81%
HALO
HALOZYME THERAPEUTICS INC
$5.06B204.80%15.80%22.65%17.70%19.686.6476.80%34.00%44.27%
GMAB
GENMAB A
$19.65B17.60%15.70%23.76%41.70%0.1312.4697.70%30.70%45.37%
UTHR
UNITED THERAPEUTICS CORP
$11.64B18.70%15.40%25.55%25.60%0.223.7888.90%42.00%57.63%
TGTX
TG THERAPEUTICS INC
$2.50B12.90%4.70%9.31%12.00%1.055.9294.00%5.40%10.99%
ROIV
ROIVANT SCIENCES LTD
$9.18B196.20%128.50%64.37%590.00%0.1227.7987.60%3,624.10%3,691.45%
RPRX
ROYALTY PHARMA PLC
$16.97B11.50%6.80%8.15%6.20%0.627.90100.00%48.20%56.15%
MEIP
MEI PHARMA INC
$20.39M39.70%18.30%28.15%27.70%0.328.23100.00%27.30%27.32%
BNTX
BIONTECH SE
$22.04B4.60%4.20%5.78%16.10%0.149.4384.30%24.40%31.68%
MDXG
MIMEDX GROUP INC
$1.09B103.30%35.90%25.77%43.20%0.423.2983.50%22.20%13.82%
REGN
REGENERON PHARMACEUTICALS INC
$105.45B15.10%11.80%13.36%14.40%0.275.2786.30%29.40%31.40%
VNDA
VANDA PHARMACEUTICALS INC
$280.78M0.50%0.40%1.13%2.00%0.194.9492.30%1.30%3.29%
SRPT
SAREPTA THERAPEUTICS INC
$12.63B2.00%0.50%1.30%1.00%2.364.0588.20%1.20%2.43%
SPRO
SPERO THERAPEUTICS INC
$87.81M32.60%18.20%17.49%130.70%0.713.53100.00%22.00%24.48%
AVRO
AVROBIO INC
$54.73M13.00%11.30%10.68%396.50%0.0715.78N/AN/AN/A
BNOX
BIONOMICS LIMITED
$11.09M-80.80%-65.20%-89.96%28,812.60%0.343.81100.00%-140,642.50%-140,487.81%
VRTX
VERTEX PHARMACEUTICALS INC
$103.60B22.60%17.30%23.06%69.80%0.293.9987.20%36.70%44.83%
KRYS
KRYSTAL BIOTECH INC
$4.56B1.60%1.50%1.64%3.20%0.0517.7793.90%21.60%25.44%
CPRX
CATALYST PHARMACEUTICALS INC
$1.73B19.80%16.50%23.98%190.70%0.212.8886.90%17.90%23.73%
CRSP
CRISPR THERAPEUTICS AG
$4.49B-8.40%-7.00%-7.11%-8.10%0.1817.54100.00%-41.40%-40.60%
TFFP
TFF PHARMACEUTICALS INC
$5.11M-163.10%-144.80%-221.31%-476.70%0.263.13100.00%-2,894.70%-2,894.68%
KNSA
KINIKSA PHARMACEUTICALS LTD
$1.42B2.10%1.70%-4.73%-6.70%0.204.2187.80%2.90%-7.15%
OCUP
OCUPHIRE PHARMA INC
$49.38M-22.30%-20.30%-19.99%-544.60%0.0813.35100.00%-52.40%-52.36%
PLX
PROTALIX BIOTHERAPEUTICS INC
$83.28M29.70%10.20%26.89%24.60%1.521.5464.90%12.70%15.97%
SEER
SEER INC
$145.09M-20.90%-19.00%-20.39%-20.30%0.1025.0051.10%-517.80%-517.84%
ADAG
ADAGENE INC
$106.32M-24.70%-14.10%-19.16%148.00%0.643.61100.00%-104.60%-89.15%
JAZZ
JAZZ PHARMACEUTICALS PLC
$6.93B9.20%2.90%5.32%7.30%2.062.2789.50%8.60%13.51%
MIRM
MIRUM PHARMACEUTICALS INC
$1.21B-88.60%-31.50%-26.33%-48.60%1.604.4574.80%-87.70%-79.04%
IMMP
IMMUTEP LTD
$335.25M-42.10%-38.60%-34.53%-1,232.30%0.0717.24100.00%-602.00%-601.76%
VYNE
VYNE THERAPEUTICS INC
$36.94M-79.10%-64.20%-31.56%-217.40%0.1012.73100.00%-6,710.40%-6,710.38%
DBVT
DBV TECHNOLOGIES SA
$128.64M-46.40%-35.30%-49.93%-670.90%0.314.26100.00%-462.40%-462.35%
PRTA
PROTHENA CORP PUBLIC LTD CO
$1.23B-24.80%-20.20%-25.09%-963.10%0.2411.24100.00%-160.90%-175.64%
IDYA
IDEAYA BIOSCIENCES INC
$3.14B-23.00%-21.80%-18.15%-30.20%0.0519.65100.00%-483.00%-483.05%
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$68.14M-22.20%-18.80%-24.33%-66.60%0.208.6281.80%-64.00%-68.55%
RNA
AVIDITY BIOSCIENCES INC
$2.11B-39.70%-35.00%-38.74%-50.00%0.267.58100.00%-2,219.90%-2,219.87%
VTGN
VISTAGEN THERAPEUTICS INC
$121.61M-72.10%-61.30%-25.27%-922.40%0.0630.76100.00%-3,076.60%-3,076.34%
LPCN
LIPOCINE INC
$24.88M-63.30%-58.30%-80.27%-76.90%0.138.69100.00%573.60%573.57%
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
$733.98M-10.10%-6.60%-12.80%-105.70%0.544.72100.00%-17.80%-26.67%
ORMP
ORAMED PHARMACEUTICALS INC
$95.22M3.60%2.90%4.52%4.20%0.353.06100.00%412.30%564.33%
INM
INMED PHARMACEUTICALS INC
$1.47M-54.30%-46.20%-46.76%-379.90%0.197.0338.40%-115.80%-115.69%
ALGS
ALIGOS THERAPEUTICS INC
$61.29M-116.40%-75.40%-69.05%-1,017.50%0.655.90100.00%-564.60%-567.50%
KZR
KEZAR LIFE SCIENCES INC
$62.39M-45.90%-40.00%-49.30%-44.10%0.1811.66100.00%-1,455.30%-1,433.14%
GNFT
GENFIT SA
$182.40M-35.60%-14.80%-16.91%-30.40%1.562.94100.00%-75.70%-59.99%
MDWD
MEDIWOUND LTD
$171.99M-20.20%-10.10%-8.34%-11.80%1.104.5919.10%-35.90%-24.83%
ZYME
ZYMEWORKS INC
$650.48M-28.40%-22.00%-25.73%-33.40%0.266.92100.00%-249.60%-253.36%
ANIX
ANIXA BIOSCIENCES INC
$93.79M-42.40%-40.90%-45.31%-48.80%0.0715.1923.30%-5,116.20%-5,116.19%
AXSM
AXSOME THERAPEUTICS INC
$3.54B-112.40%-43.70%-51.59%-138.50%2.083.6390.40%-88.40%-85.67%
LEGN
LEGEND BIOTECH CORP
$8.26B-44.60%-30.40%-30.53%-73.10%0.486.9249.40%-181.80%-174.76%
NVO
NOVO NORDISK A S
$554.96B91.80%29.90%84.19%133.20%2.020.7084.60%36.60%45.95%
AGIO
AGIOS PHARMACEUTICALS INC
$1.96B-41.40%-36.40%-44.19%-39.30%0.1412.8490.00%-1,199.30%-1,199.26%
PTGX
PROTAGONIST THERAPEUTICS INC
$1.52B-27.50%-25.30%-23.45%-83.60%0.0616.71100.00%-131.60%-131.59%
FULC
FULCRUM THERAPEUTICS INC
$480.00M-36.60%-33.60%-39.89%-38.20%0.1017.71100.00%-3,470.10%-3,470.05%
XCUR
EXICURE INC
$4.33M34.50%13.10%20.31%25.00%0.812.56100.00%12.90%13.76%
MRUS
MERUS NV
$2.80B-50.60%-37.60%-43.03%-86.50%0.285.34100.00%-352.60%-378.31%
FUSN
FUSION PHARMACEUTICALS INC
$1.82B-46.60%-35.30%-32.99%-34.50%0.2915.01100.00%-4,588.80%-4,300.97%
ACIU
AC IMMUNE SA
$237.08M-37.50%-33.30%-31.94%-105.20%0.149.22100.00%-366.40%-365.16%
FATE
FATE THERAPEUTICS INC
$402.90M-38.20%-28.40%-34.45%-28.10%0.378.48100.00%-253.30%-253.30%
ARGX
ARGENX SE
$22.98B-8.50%-7.70%-7.37%-15.80%0.119.75-231.60%-830.40%-854.39%
XBIO
XENETIC BIOSCIENCES INC
$6.58M-36.40%-33.70%-42.21%-419.10%0.0811.84100.00%-162.80%-162.78%
SLGL
SOL-GEL TECHNOLOGIES LTD
$23.68M-62.60%-54.70%-66.82%-112.20%0.179.10100.00%-1,752.80%-1,752.77%
CLNN
CLENE INC
$55.87M-362.00%-89.80%-166.40%-122.70%2.911.5381.50%-7,569.40%-6,872.48%
JANX
JANUX THERAPEUTICS INC
$3.35B-17.90%-16.00%-15.87%-16.70%0.1126.80100.00%-721.20%-721.18%
IGMS
IGM BIOSCIENCES INC
$591.98M-103.20%-53.50%-64.51%-78.50%1.088.18100.00%-11,568.80%-11,537.00%
VERV
VERVE THERAPEUTICS INC
$536.00M-39.30%-30.90%-27.92%-35.30%0.2617.24100.00%-1,701.50%-1,699.21%
TRAW
TRAWS PHARMA INC
$13.38M-113.20%-65.80%-140.74%240.20%1.132.46100.00%-8,384.10%-8,384.07%
MRKR
MARKER THERAPEUTICS INC
$37.57M-50.10%-38.10%-58.59%-143.70%0.225.57100.00%-248.80%-248.65%
ZVRA
ZEVRA THERAPEUTICS INC
$208.88M-68.40%-35.20%-45.18%-73.00%1.791.1889.30%-167.70%-162.22%
ALT
ALTIMMUNE INC
$517.54M-52.00%-47.30%-44.54%-153.20%0.0917.26100.00%-20,762.20%-20,753.99%
ITOS
ITEOS THERAPEUTICS INC
$417.93M-18.40%-16.20%-17.37%-24.50%0.1613.76100.00%-894.30%-865.66%
CDIO
CARDIO DIAGNOSTICS HOLDINGS INC
$16.56M-289.40%-130.20%-45.34%1,418.50%0.513.29100.00%-49,087.80%-9,620.98%
PLRX
PLIANT THERAPEUTICS INC
$842.14M-31.20%-29.00%-33.10%-33.90%0.0817.72100.00%-10,211.10%-10,130.95%
BGNE
BEIGENE LTD
$16.98B-23.10%-15.30%-22.52%-54.70%0.642.3284.50%-35.90%-36.60%
SPRB
SPRUCE BIOSCIENCES INC
$30.61M-52.30%-39.80%-59.68%-459.90%0.364.18100.00%-475.00%-470.18%
TECH
BIO-TECHNE CORP
$12.15B11.50%8.40%10.12%18.30%0.394.3767.10%19.60%22.94%
RVMD
REVOLUTION MEDICINES INC
$6.62B-38.40%-33.60%-22.92%-59.70%0.1313.06100.00%-3,768.30%-3,796.10%
CALT
CALLIDITAS THERAPEUTICS AB
$595.80M-84.70%-24.50%-23.60%-43.10%4.553.1395.00%-38.60%-28.39%
BRNS
BARINTHUS BIOTHERAPEUTICS PLC
$84.85M-35.20%-30.80%-37.84%-244.70%0.1512.46100.00%-9,145.50%-9,525.44%
SPRY
ARS PHARMACEUTICALS INC
$940.89M-22.20%-21.50%-23.56%-33.90%0.0196.92100.00%-181,216.70%-181,216.67%
EYPT
EYEPOINT PHARMACEUTICALS INC
$983.66M-61.50%-33.50%-23.80%-1,558.50%0.335.4589.90%-153.80%-150.95%
RYTM
RHYTHM PHARMACEUTICALS INC
$2.63B-96.00%-55.00%-61.33%-88.40%0.965.5888.00%-238.50%-219.85%
APRE
APREA THERAPEUTICS INC
$29.05M-65.60%-52.40%-84.92%463.90%0.345.14100.00%-2,449.60%-2,659.48%
IFRX
INFLARX NV
$81.26M-40.30%-36.40%-41.24%-45.40%0.176.50-743.70%-67,630.70%-67,574.22%
SAGE
SAGE THERAPEUTICS INC
$838.94M-60.90%-54.70%-71.29%-71.60%0.0912.2296.50%-552.50%-552.52%
LXRX
LEXICON PHARMACEUTICALS INC
$428.45M-109.40%-62.50%-45.03%-63.10%0.4415.5895.00%-8,376.50%-7,674.34%
QSI
QUANTUM-SI INC
$260.86M-31.50%-29.00%-33.48%-40.70%0.1022.9445.10%-8,868.80%-8,868.76%
IMCR
IMMUNOCORE HOLDINGS PLC
$3.00B-15.50%-9.80%-12.17%-59.50%0.623.8099.60%-22.20%-22.35%
KRRO
KORRO BIO INC
$467.20M-106.30%-72.30%-40.14%-167.10%0.318.87N/AN/AN/A
ZLAB
ZAI LAB LTD
$1.61B-37.10%-30.70%-40.16%-273.40%0.304.6364.10%-125.50%-125.46%
MREO
MEREO BIOPHARMA GROUP PLC
$457.24M-46.10%-33.40%-49.81%6,381.30%0.326.7274.30%-294.70%-283.97%
VCYT
VERACYTE INC
$1.53B-7.00%-6.50%-7.27%-124.00%0.074.6668.70%-20.60%-21.22%
VRDN
VIRIDIAN THERAPEUTICS INC
$966.62M-68.30%-61.10%-50.86%-85.10%0.1118.27100.00%-75,711.50%-75,123.25%
IMTX
IMMATICS NV
$911.76M-43.50%-22.30%-27.44%-52.40%1.272.87100.00%-179.60%-179.63%
OCS
OCULIS HOLDING AG
$469.12MN/A-117.30%-91.72%-108.20%0.225.29100.00%-10,056.90%-9,895.81%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 6.15% over the past year, overperforming other biotech stocks by 24 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 65.85% from Corcept Therapeutics's current stock price of $24.52.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -20.99% over the past year, underperforming other biotech stocks by -3 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 39.37% from Incyte's current stock price of $53.76.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -92.77% over the past year, underperforming other biotech stocks by -74 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 441.87% from Amylyx Pharmaceuticals's current stock price of $2.03.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.11%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.41%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.07% in the last day, and up 6% over the last week. Ardelyx was the among the top gainers in the biotechnology industry, gaining 28.42% yesterday.

Ardelyx shares are trading higher after the company reported better-than-expected Q1 financial results.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -20.99% in the past year. It has underperformed other stocks in the biotech industry by -3 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -19.61% in the past year. It has underperformed other stocks in the biotech industry by -1 percentage points.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -92.77% in the past year. It has underperformed other stocks in the biotech industry by -74 percentage points.

Are biotech stocks a good buy now?

50.1% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 80.46% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 6.05x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.